NCT03317717

Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers

Phase 1 Study to Determine the Pharmacodynamic and Safety of MEDITOXIN®(Clostridium Botulinum Toxin Type A) in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Medy-Tox · Industry
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study will determine the pharmacodynamic and safety of MEDITOXIN® in healthy male volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Meditoxin	injection of MEDITOXIN into EDB muscle of one foot and BOTOX into the same muscle of contralateral foot in equal doses
DRUG	Botox	injection of MEDITOXIN into EDB muscle of one foot and BOTOX into the same muscle of contralateral foot in equal doses

Timeline

• Start date: 2017-10-12
• Primary completion: 2018-01-30
• Completion: 2018-01-30
• First posted: 2017-10-23
• Last updated: 2019-03-27

Locations

1 site across 1 country: South Korea